DE69533804D1 - Mimetika von aus alternden zellen abgeleitete hemmer der dna synthese - Google Patents

Mimetika von aus alternden zellen abgeleitete hemmer der dna synthese

Info

Publication number
DE69533804D1
DE69533804D1 DE69533804T DE69533804T DE69533804D1 DE 69533804 D1 DE69533804 D1 DE 69533804D1 DE 69533804 T DE69533804 T DE 69533804T DE 69533804 T DE69533804 T DE 69533804T DE 69533804 D1 DE69533804 D1 DE 69533804D1
Authority
DE
Germany
Prior art keywords
mimetica
inhibitors
dna synthesis
aging cells
synthesis derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69533804T
Other languages
English (en)
Other versions
DE69533804T2 (de
Inventor
R Smith
K Kay
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of North Carolina at Chapel Hill
Baylor College of Medicine
University of North Carolina System
Original Assignee
University of North Carolina at Chapel Hill
Baylor College of Medicine
University of North Carolina System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/249,371 external-priority patent/US5596079A/en
Priority claimed from PCT/US1994/009700 external-priority patent/WO1995006415A1/en
Priority claimed from US08/327,874 external-priority patent/US6372249B1/en
Application filed by University of North Carolina at Chapel Hill, Baylor College of Medicine, University of North Carolina System filed Critical University of North Carolina at Chapel Hill
Publication of DE69533804D1 publication Critical patent/DE69533804D1/de
Application granted granted Critical
Publication of DE69533804T2 publication Critical patent/DE69533804T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C12N2310/111—Antisense spanning the whole gene, or a large part of it
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/32—Chemical structure of the sugar
    • C12N2310/322—2'-R Modification

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Dispersion Chemistry (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69533804T 1994-05-24 1995-05-23 Mimetika von aus alternden Zellen abgeleiteten Hemmern der DNA-Synthese Expired - Lifetime DE69533804T2 (de)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US321814 1989-03-09
US08/249,371 US5596079A (en) 1991-12-16 1994-05-24 Mimetics of senescent cell derived inhibitors of DNA synthesis
US26843994A 1994-06-30 1994-06-30
US268439 1994-06-30
US27453594A 1994-07-13 1994-07-13
US274535 1994-07-13
WOPCT/US94/09700 1994-08-26
PCT/US1994/009700 WO1995006415A1 (en) 1993-08-30 1994-08-26 Senescent cell-derived inhibitors of dna synthesis
US32181494A 1994-10-03 1994-10-03
US327874 1994-10-24
US08/327,874 US6372249B1 (en) 1991-12-16 1994-10-24 Senscent cell-derived inhibitors of DNA synthesis
PCT/US1995/006451 WO1995031995A1 (en) 1994-05-24 1995-05-23 Mimetics of senescent cell derived inhibitors of dna synthesis
US249371 1999-02-12

Publications (2)

Publication Number Publication Date
DE69533804D1 true DE69533804D1 (de) 2004-12-30
DE69533804T2 DE69533804T2 (de) 2006-05-11

Family

ID=27557474

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69533804T Expired - Lifetime DE69533804T2 (de) 1994-05-24 1995-05-23 Mimetika von aus alternden Zellen abgeleiteten Hemmern der DNA-Synthese

Country Status (6)

Country Link
EP (1) EP0783317B1 (de)
AT (1) ATE283355T1 (de)
AU (1) AU2644495A (de)
DE (1) DE69533804T2 (de)
ES (1) ES2233943T3 (de)
WO (1) WO1995031995A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9422175D0 (en) 1994-11-03 1994-12-21 Univ Dundee Indentification of the p21 waf1-pcna interaction site and therapeutic applications thereof
ATE333465T1 (de) 1996-05-08 2006-08-15 Cyclacel Ltd Methoden und mittel zur hemmung der cdk4- aktivität
NZ546983A (en) 2003-11-24 2009-05-31 Canji Inc Reduction of dermal scarring
ES2403558T3 (es) 2004-08-27 2013-05-20 Cyclacel Limited Inhibidores purínicos y pirimidínicos de CDK y su uso para el tratamiento de enfermedades autoinmunitarias

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994009135A1 (en) * 1992-10-16 1994-04-28 Cold Spring Harbor Laboratory Cyclin complex rearrangement and uses related thereto
US5302706A (en) * 1991-12-16 1994-04-12 Baylor College Of Medicine Senescent cell derived inhibitors of DNA synthesis
CA2170641C (en) * 1993-08-30 2011-11-15 James R. Smith Senescent cell-derived inhibitors of dna synthesis
WO1995011986A1 (en) * 1993-10-27 1995-05-04 The Trustees Of Columbia University In The City Of New York METHOD FOR GENERATING A SUBTRACTED cDNA LIBRARY AND USES OF THE GENERATED LIBRARY
WO1995013375A1 (en) * 1993-11-10 1995-05-18 The Johns Hopkins University Tumor suppressor waf1
GB9422175D0 (en) * 1994-11-03 1994-12-21 Univ Dundee Indentification of the p21 waf1-pcna interaction site and therapeutic applications thereof

Also Published As

Publication number Publication date
EP0783317A4 (de) 1997-12-10
EP0783317A1 (de) 1997-07-16
ES2233943T3 (es) 2005-06-16
WO1995031995A1 (en) 1995-11-30
AU2644495A (en) 1995-12-18
DE69533804T2 (de) 2006-05-11
EP0783317B1 (de) 2004-11-24
ATE283355T1 (de) 2004-12-15

Similar Documents

Publication Publication Date Title
NO961812L (no) Humanproteaseinhibitorer av Kunitz-type
DE69730235D1 (de) Neuartige Verfahren und Zusammensetzungen zur Entdeckung von neuen multimerischen Molekülen, basierend auf einer kombinatorisichen Bibliothek
ES2180782T3 (es) Procedimiento para la identificacion o el aislamiento de una molecula y moleculas identificadas de ese modo.
FI925986A (fi) Slumpartat bio-oligomer bibliotek, ett foerfarande foer syntetisering avdet samt ett foerfarande foer anvaendning av det
DE60029572D1 (de) Isolierung und analyse von proteinen
DE60035204D1 (de) Tyrosinderivate
DE69830497D1 (de) Bibliothek für die in vitro expression von peptiden oder proteinen
ATE282713T1 (de) Screening-verfahren zur identifizierung von neuen antibiotika
NO975731L (no) Katalytisk DNA
DE60129008D1 (de) Methode zur identifizierung von regulatoren der bildung von protein-age-derivaten
DE69605934T2 (de) Cyclin-abhängige kinase bindende verbindungen
DE69835531D1 (de) Methode mit hoher durchsatzrate zur funktionellen klassifizierung von in einem genomischen versuchsansatz identifizierten proteinen
WO2004092346A3 (en) Small molecule inhibition of a pdz-domain interaction
ATE355295T1 (de) Synthese von oligosacchariden, reagenzien und verfahren
WO1997012039A3 (en) Sh2-containing inositol-phosphatase
DE69533804D1 (de) Mimetika von aus alternden zellen abgeleitete hemmer der dna synthese
ATE240921T1 (de) Verfahren zur etherifizierung von benzylalkoholen,erhaltene produkte und ihre verwendungen
GB0123664D0 (en) Histone deacetylase 9
SE9404072D0 (sv) Novel polypeptides
TR200003695T2 (tr) Anjiyostatin bağlayıcı protein.
ATE285478T1 (de) Zellulosefilme zur durchfuehrung von screening- verfahren
WO2023056379A3 (en) Sorting of oligonucleotide-directed combinatorial libraries
Kim et al. Genetic polymorphism of protease inhibitor (PI) in Korean population
DE69435309D1 (de) Inhibitoren der dna synthese aus alternden zellen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition